Dianthus Therapeutics DNTH Issuance Costs In Connection With Public Offering Included In Accrued Expenses
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept dnth:IssuanceCostsInConnectionWithPublicOfferingIncludedInAccruedExpenses.
The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Dianthus Therapeutics's issuance costs in connection with public offering included in accrued expenses?
- Dianthus Therapeutics (DNTH) reported issuance costs in connection with public offering included in accrued expenses of $151K in Q1 2026.